Abel Vieira de Melo Bisneto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abel Vieira de Melo Bisneto has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Lee Chen-Chen
Federal University of Goiás
8 shared publications - Clever Gomes Cardoso
Universidade Federal de Goiás
5 shared publications - Amanda Silva Fernandes
Pontifical Catholic University of Goiás
3 shared publications - Cristiene Costa Carneiro
Pontificia Universidade Catolica de Goias
3 shared publications - Elisa Flávia Luiz Cardoso Bailão
Central Campus, State University of Goiás
3 shared publications - Jefferson Hollanda Véras
Institute of Biological Sciences, Federal University of Goiás, Goiânia-GO, Brazil
3 shared publications
Latest Publications
- 11 July 2026
- Published by Oxford University Press (OUP) in Toxicology Research
- Vol. 15 (4)
Cytotoxic but not genotoxic: toxicological evaluation of the herbicide mixture S-metolachlor + flumioxazin in human cells, rodents, and bacteria
Flumioxazin and S-metolachlor are widely used in soybean cultivation and frequently co-occur in the environment due to their persistence. This study investigated the cytotoxic, genotoxic, and mutagenic potential of a commercial formulation containing this herbicide mixture using an integrated in vitro and in vivo approach. Cytotoxicity was assessed in human erythrocytes and lymphocytes, while mutagenicity was evaluated using the Ames test with Salmonella typhimurium strains TA98 and TA100, without metabolic activation. In vivo genotoxicity was examined in Wistar rats orally exposed for 28 days, followed by the comet assay in bone marrow. The mixture induced concentration-dependent cytotoxicity, with significant hemolysis (EC50 0.093 mg/mL) and reduced lymphocyte viability (IC50 0.219 mg/mL). In contrast, no genotoxic alterations were detected in bone marrow comet assay parameters (250, 500, and 1,000 mg/kg), and mutagenic activity was not confirmed according to Ames test criteria (0.06 to 18.90 mg/plate). Collectively, these findings indicate that, although the mixture exhibited marked cytotoxicity in human cells, it did not show detectable genotoxic or mutagenic effects under the specific experimental conditions tested. These conclusions should be interpreted within the limitations of the present study, particularly the use of only TA98 and TA100 strains, the absence of metabolic activation in the Ames test, and the evaluation of bone marrow as the only tissue in the in vivo comet assay. The cytotoxic effects observed at field-dose-derived concentrations suggest the importance of further ecotoxicological evaluations, particularly regarding potential risks to non-target organisms with limited detoxification capacity.
- 11 July 2026
- Published by Oxford University Press (OUP) in Toxicology Research
- Vol. 15 (4)
Cytotoxic but not genotoxic: toxicological evaluation of the herbicide mixture S-metolachlor + flumioxazin in human cells, rodents, and bacteria
Flumioxazin and S-metolachlor are widely used in soybean cultivation and frequently co-occur in the environment due to their persistence. This study investigated the cytotoxic, genotoxic, and mutagenic potential of a commercial formulation containing this herbicide mixture using an integrated in vitro and in vivo approach. Cytotoxicity was assessed in human erythrocytes and lymphocytes, while mutagenicity was evaluated using the Ames test with Salmonella typhimurium strains TA98 and TA100, without metabolic activation. In vivo genotoxicity was examined in Wistar rats orally exposed for 28 days, followed by the comet assay in bone marrow. The mixture induced concentration-dependent cytotoxicity, with significant hemolysis (EC50 0.093 mg/mL) and reduced lymphocyte viability (IC50 0.219 mg/mL). In contrast, no genotoxic alterations were detected in bone marrow comet assay parameters (250, 500, and 1,000 mg/kg), and mutagenic activity was not confirmed according to Ames test criteria (0.06 to 18.90 mg/plate). Collectively, these findings indicate that, although the mixture exhibited marked cytotoxicity in human cells, it did not show detectable genotoxic or mutagenic effects under the specific experimental conditions tested. These conclusions should be interpreted within the limitations of the present study, particularly the use of only TA98 and TA100 strains, the absence of metabolic activation in the Ames test, and the evaluation of bone marrow as the only tissue in the in vivo comet assay. The cytotoxic effects observed at field-dose-derived concentrations suggest the importance of further ecotoxicological evaluations, particularly regarding potential risks to non-target organisms with limited detoxification capacity.
- 3 August 2025
- Published by Taylor & Francis in Journal of Environmental Science and Health, Part B
- Vol. 60 (8) , 379-387
Screening of fluopyram-based formulation toxicity in non-target organisms
Fluopyram is a fungicide with nematicidal properties widely used in agriculture, found in commercial products for agricultural pest management. Despite its increasing agricultural use, limited information exists on its cytogenotoxic and plant-level impacts. This study evaluated the cytogenotoxic and ecotoxicological effects of a fluopyram-based formulation on non-target organisms, including Salmonella typhimurium (TA98 and TA100 strains), Artemia salina, and seeds of Lactuca sativa (lettuce), Allium cepa (onion), and Cucumis sativus (cucumber). Concentrations ranging from 0.017 to 5.00 mg mL-1 were tested. The pesticide did not induce mutagenic responses in the Salmonella strains tested but demonstrated cytotoxicity at high concentrations (≥1.67 mg mL-1). In A. salina, increasing mortality was observed from 0.210 mg mL-1, with an estimated LC50 of 1.021 mg mL-1. Regarding germination, onion seeds were affected at the highest tested concentration, while root growth in plant species exhibited a hormetic response, with stimulation at low concentrations and inhibition at higher ones. These findings underscore the need for continued environmental monitoring and risk assessment of fluopyram-based formulations, particularly regarding aquatic and plant ecosystems.
- 3 August 2025
- Published by Taylor & Francis in Journal of Environmental Science and Health, Part B
- Vol. 60 (8) , 379-387
Screening of fluopyram-based formulation toxicity in non-target organisms
Fluopyram is a fungicide with nematicidal properties widely used in agriculture, found in commercial products for agricultural pest management. Despite its increasing agricultural use, limited information exists on its cytogenotoxic and plant-level impacts. This study evaluated the cytogenotoxic and ecotoxicological effects of a fluopyram-based formulation on non-target organisms, including Salmonella typhimurium (TA98 and TA100 strains), Artemia salina, and seeds of Lactuca sativa (lettuce), Allium cepa (onion), and Cucumis sativus (cucumber). Concentrations ranging from 0.017 to 5.00 mg mL-1 were tested. The pesticide did not induce mutagenic responses in the Salmonella strains tested but demonstrated cytotoxicity at high concentrations (≥1.67 mg mL-1). In A. salina, increasing mortality was observed from 0.210 mg mL-1, with an estimated LC50 of 1.021 mg mL-1. Regarding germination, onion seeds were affected at the highest tested concentration, while root growth in plant species exhibited a hormetic response, with stimulation at low concentrations and inhibition at higher ones. These findings underscore the need for continued environmental monitoring and risk assessment of fluopyram-based formulations, particularly regarding aquatic and plant ecosystems.
- Open Access
- 31 December 2024
- Published by Sociedade Brasileira de Plantas Medicinais in Revista Brasileira de Plantas Medicinais
- Vol. 26 (1) , 11-19
Angiogenic potential of “Quina do Cerrado” (Strychnos pseudoquina)
Leaf and bark infusions of the Strychnos pseudoquina A.St.-Hil., Loganiaceae, plant have long been used in Brazilian traditional medicine for the treatment of various diseases and medical conditions, showing apparent antipyretic, gastric cicatrizant, and especially antimalarial effects. The literature contains abundant reports of plants that possess bioactive components with therapeutic properties. The search for natural substances that promote or inhibit angiogenesis is the focus of current research, since numerous drugs derived from plants have these effects. Thus, in this study, we investigated the angiogenic potential of S. pseudoquina, using the embryonated chicken egg chorioallantoic membrane assay for the angiogenesis tests. Three concentrations of an aqueous extract of S. pseudoquina bark were tested: 15, 30, and 60 mg/ml. The mean percentages of vascularization of CAMs treated with these three extract concentrations were 15.4%, 17.1%, and 17.2%, respectively, which were significantly higher (p<0.05) than that in the negative (8.9%) and inhibitor controls (2.2%). Therefore, it was concluded that the aqueous extract of S. pseudoquina can promote angiogenesis at the concentrations tested.
- 31 December 2024
- Published by Sociedade Brasileira de Plantas Medicinais in Revista Brasileira de Plantas Medicinais
- Vol. 26 (1) , 11-19
Open AccessAngiogenic potential of “Quina do Cerrado” (Strychnos pseudoquina)
Leaf and bark infusions of the Strychnos pseudoquina A.St.-Hil., Loganiaceae, plant have long been used in Brazilian traditional medicine for the treatment of various diseases and medical conditions, showing apparent antipyretic, gastric cicatrizant, and especially antimalarial effects. The literature contains abundant reports of plants that possess bioactive components with therapeutic properties. The search for natural substances that promote or inhibit angiogenesis is the focus of current research, since numerous drugs derived from plants have these effects. Thus, in this study, we investigated the angiogenic potential of S. pseudoquina, using the embryonated chicken egg chorioallantoic membrane assay for the angiogenesis tests. Three concentrations of an aqueous extract of S. pseudoquina bark were tested: 15, 30, and 60 mg/ml. The mean percentages of vascularization of CAMs treated with these three extract concentrations were 15.4%, 17.1%, and 17.2%, respectively, which were significantly higher (p<0.05) than that in the negative (8.9%) and inhibitor controls (2.2%). Therefore, it was concluded that the aqueous extract of S. pseudoquina can promote angiogenesis at the concentrations tested.
- 11 December 2023
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 87 (5) , 185-198
Tellimagrandin-I and camptothin a exhibit chemopreventive effects in Salmonella enterica serovar Typhimurium strains and human lymphocytes
Tellimagrandin-I (TL) and camptothin A (CA) are ellagitannins widely found in diverse plant species. Numerous studies demonstrated their significant biological activities, which include antitumor, antioxidant, and hepatoprotective properties. Despite this protective profile, the effects of TL and CA on DNA have not been comprehensively investigated. Thus, the aim of this study was to determine the mutagenic and antimutagenic effects attributed to TL and CA exposure on Salmonella enterica serovar Typhimurium strains using the Ames test. In addition, the cytotoxic and genotoxic effects were examined on human lymphocytes, employing both trypan blue exclusion and CometChip assay. The antigenotoxic effect was determined following TL and CA exposure in the presence of co-treatment with doxorubicin (DXR). Our results from the Ames test indicated that TL or CA did not display marked mutagenic activity. However, TL or CA demonstrated an ability to protect DNA against the damaging effects of the mutagens 4-nitroquinoline-1-oxide and sodium azide, thereby exhibiting antimutagenic properties. In relation to human lymphocytes, TL or CA did not induce significant cytotoxic or genotoxic actions on these cells. Further, these ellagitannins exhibited an ability to protect DNA from damage induced by DOX during co-treatment, indicating their potential beneficial usefulness as antigenotoxic agents. In conclusion, the protective effects of TL or CA against mutagens, coupled with their absence of genotoxic and cytotoxic effects on human lymphocytes, emphasize their potential therapeutic value in chemopreventive strategies.
- 11 December 2023
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 87 (5) , 185-198
Tellimagrandin-I and camptothin a exhibit chemopreventive effects in Salmonella enterica serovar Typhimurium strains and human lymphocytes
Tellimagrandin-I (TL) and camptothin A (CA) are ellagitannins widely found in diverse plant species. Numerous studies demonstrated their significant biological activities, which include antitumor, antioxidant, and hepatoprotective properties. Despite this protective profile, the effects of TL and CA on DNA have not been comprehensively investigated. Thus, the aim of this study was to determine the mutagenic and antimutagenic effects attributed to TL and CA exposure on Salmonella enterica serovar Typhimurium strains using the Ames test. In addition, the cytotoxic and genotoxic effects were examined on human lymphocytes, employing both trypan blue exclusion and CometChip assay. The antigenotoxic effect was determined following TL and CA exposure in the presence of co-treatment with doxorubicin (DXR). Our results from the Ames test indicated that TL or CA did not display marked mutagenic activity. However, TL or CA demonstrated an ability to protect DNA against the damaging effects of the mutagens 4-nitroquinoline-1-oxide and sodium azide, thereby exhibiting antimutagenic properties. In relation to human lymphocytes, TL or CA did not induce significant cytotoxic or genotoxic actions on these cells. Further, these ellagitannins exhibited an ability to protect DNA from damage induced by DOX during co-treatment, indicating their potential beneficial usefulness as antigenotoxic agents. In conclusion, the protective effects of TL or CA against mutagens, coupled with their absence of genotoxic and cytotoxic effects on human lymphocytes, emphasize their potential therapeutic value in chemopreventive strategies.
- 20 September 2023
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 86 (24) , 929-941
Chemopreventive effect and induction of DNA repair by oenothein B ellagitannin isolated from leaves of Eugenia uniflora in Swiss Webster treated mice
Oenothein B (OeB) is a dimeric ellagitannin with potent antioxidative, antitumor, immunomodulatory, and anti-inflammatory properties. Despite the promising activities of OeB, studies examining the genotoxic or protective effects of this ellagitannin on DNA are scarce. Therefore, to further comprehensively elucidate the chemopreventive profile of OeB, the aim of this study was to evaluate the mutagenic and antimutagenic actions of OeB using Salmonella typhimurium strains with the Ames test. The micronucleus (MN) test and comet assay were used to assess the anticytotoxic and antigenotoxic effects of OeB on mouse bone marrow cells following differing treatments (pre-, co-, and post-treatment) in response to cyclophosphamide (CPA)-induced DNA damage. In addition, histopathological analyses were performed to assess liver and kidney tissues of Swiss Webster treated mice. Our results did not detect mutagenic or antimutagenic activity attributed to OeB at any concentration in the Ames test. Regarding the MN test, data showed that this ellagitannin exerted antigenotoxic and anticytotoxic effects against CPA-induced DNA damage under all treatment conditions. However, no anticytotoxic action was observed in MN test after pre-treatment with the highest doses of OeB. In addition, OeB demonstrated antigenotoxic effects in the comet assay for all treatments. Histopathological analyses indicated that OeB attenuated the toxic effects of CPA in mouse liver and kidneys. These findings suggest that OeB exerted a chemoprotective effect following pre- and co-treatments and a DNA repair action in post-treatment experiments. Our findings indicate that OeB protects DNA against CPA-induced damaging agents and induces post-damage DNA repair.
- 20 September 2023
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 86 (24) , 929-941
Chemopreventive effect and induction of DNA repair by oenothein B ellagitannin isolated from leaves of Eugenia uniflora in Swiss Webster treated mice
Oenothein B (OeB) is a dimeric ellagitannin with potent antioxidative, antitumor, immunomodulatory, and anti-inflammatory properties. Despite the promising activities of OeB, studies examining the genotoxic or protective effects of this ellagitannin on DNA are scarce. Therefore, to further comprehensively elucidate the chemopreventive profile of OeB, the aim of this study was to evaluate the mutagenic and antimutagenic actions of OeB using Salmonella typhimurium strains with the Ames test. The micronucleus (MN) test and comet assay were used to assess the anticytotoxic and antigenotoxic effects of OeB on mouse bone marrow cells following differing treatments (pre-, co-, and post-treatment) in response to cyclophosphamide (CPA)-induced DNA damage. In addition, histopathological analyses were performed to assess liver and kidney tissues of Swiss Webster treated mice. Our results did not detect mutagenic or antimutagenic activity attributed to OeB at any concentration in the Ames test. Regarding the MN test, data showed that this ellagitannin exerted antigenotoxic and anticytotoxic effects against CPA-induced DNA damage under all treatment conditions. However, no anticytotoxic action was observed in MN test after pre-treatment with the highest doses of OeB. In addition, OeB demonstrated antigenotoxic effects in the comet assay for all treatments. Histopathological analyses indicated that OeB attenuated the toxic effects of CPA in mouse liver and kidneys. These findings suggest that OeB exerted a chemoprotective effect following pre- and co-treatments and a DNA repair action in post-treatment experiments. Our findings indicate that OeB protects DNA against CPA-induced damaging agents and induces post-damage DNA repair.
- Open Access
- 1 January 2023
- Published by Comprehensive Publications in International Journal of Biology Sciences
- Vol. 5 (2) , 47-50
Aqueous extract of Strychnos pseudoquina exhibits no mutagenicity but shows increased mutagenicity upon interaction with sodium azide
The infusion of Strychnos pseudoquina leaves and bark has been used in folk medicine to treat fevers, malaria, liver and stomach conditions, and anemia. Despite its popular use, the mutagenic effects of S. pseudoqunia are unclear. It is important to note that species of this same genus are generally classified as both toxic and mutagenic. The present study evaluated the mutagenic and antimutagenic potential of an aqueous extract of S. pseudoquina bark using the Ames test in Salmonella typhimurium. The concentrations of 0.62, 1.25, 2.5, 5, and 10 mg/plate of S. pseudoquina were evaluated. The results revealed the absence of mutagenicity and antimutagenicity for all tested concentrations of S. pseudoquina, suggesting the potential medicinal value for this plant. Importantly, S. pseudoquina solution can interact with other drugs. We observed that the aqueous extract of S. pseudoquina bark increased the mutagenicity of sodium azide in S. typhimurium by as-yet unknown components and mechanisms. Thus, despite not having mutagenic or antimutagenic actions, the use in association with other drugs may bring unwanted effects. Further scientific data are required to guide clinical practice and safeguard the welfare of users.
- 1 January 2023
- Published by Comprehensive Publications in International Journal of Biology Sciences
- Vol. 5 (2) , 47-50
Open AccessAqueous extract of Strychnos pseudoquina exhibits no mutagenicity but shows increased mutagenicity upon interaction with sodium azide
The infusion of Strychnos pseudoquina leaves and bark has been used in folk medicine to treat fevers, malaria, liver and stomach conditions, and anemia. Despite its popular use, the mutagenic effects of S. pseudoqunia are unclear. It is important to note that species of this same genus are generally classified as both toxic and mutagenic. The present study evaluated the mutagenic and antimutagenic potential of an aqueous extract of S. pseudoquina bark using the Ames test in Salmonella typhimurium. The concentrations of 0.62, 1.25, 2.5, 5, and 10 mg/plate of S. pseudoquina were evaluated. The results revealed the absence of mutagenicity and antimutagenicity for all tested concentrations of S. pseudoquina, suggesting the potential medicinal value for this plant. Importantly, S. pseudoquina solution can interact with other drugs. We observed that the aqueous extract of S. pseudoquina bark increased the mutagenicity of sodium azide in S. typhimurium by as-yet unknown components and mechanisms. Thus, despite not having mutagenic or antimutagenic actions, the use in association with other drugs may bring unwanted effects. Further scientific data are required to guide clinical practice and safeguard the welfare of users.
- 1 May 2021
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 865, 503334
Prednisone is genotoxic in mice and Drosophila melanogaster
- 1 May 2021
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 865, 503334
Prednisone is genotoxic in mice and Drosophila melanogaster
- 29 December 2020
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 84 (6) , 261-271
Recombinogenic, genotoxic, and cytotoxic effects of azathioprine using in vivo assays
Azathioprine (Aza) is a purine antimetabolite immunosuppressant that is widely employed for immunosuppressive therapy in post-transplant recipients or patients with autoimmune diseases. Chronic use of immunosuppressants might produce several side effects, including a high rate of neoplasms in these patients. Considering that genotoxic effects are associated with an increased risk of developing cancer, the aim of this study was to examine the recombinogenic, genotoxic, and cytotoxic effects of Aza using Somatic Mutation and Recombination Test (SMART) in Drosophila melanogaster, as well as comet and micronucleus assays in mouse bone marrow cells. Further, the adverse effects of Aza were determined in mouse hepatic and renal tissues using histopathological analysis. Data demonstrated that Aza induced significant increased genotoxicity in D. melanogaster and mouse bone marrow cells at all concentrations tested. Homologous recombination was the predominant genotoxic event noted for the first time to be initiated by Aza in SMART. In histopathological analysis, Aza did not show any marked toxic activity in mouse hepatic and renal tissues. Therefore, the high rate of neoplasms reported in patients with long-term use of Aza may be attributed, at least partially, to the genotoxic action of this drug.
- 29 December 2020
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 84 (6) , 261-271
Recombinogenic, genotoxic, and cytotoxic effects of azathioprine using in vivo assays
Azathioprine (Aza) is a purine antimetabolite immunosuppressant that is widely employed for immunosuppressive therapy in post-transplant recipients or patients with autoimmune diseases. Chronic use of immunosuppressants might produce several side effects, including a high rate of neoplasms in these patients. Considering that genotoxic effects are associated with an increased risk of developing cancer, the aim of this study was to examine the recombinogenic, genotoxic, and cytotoxic effects of Aza using Somatic Mutation and Recombination Test (SMART) in Drosophila melanogaster, as well as comet and micronucleus assays in mouse bone marrow cells. Further, the adverse effects of Aza were determined in mouse hepatic and renal tissues using histopathological analysis. Data demonstrated that Aza induced significant increased genotoxicity in D. melanogaster and mouse bone marrow cells at all concentrations tested. Homologous recombination was the predominant genotoxic event noted for the first time to be initiated by Aza in SMART. In histopathological analysis, Aza did not show any marked toxic activity in mouse hepatic and renal tissues. Therefore, the high rate of neoplasms reported in patients with long-term use of Aza may be attributed, at least partially, to the genotoxic action of this drug.